vs
AGIOS PHARMACEUTICALS, INC.（AGIO）与Dominari Holdings Inc.（DOMH）财务数据对比。点击上方公司名可切换其他公司
Dominari Holdings Inc.的季度营收约是AGIOS PHARMACEUTICALS, INC.的1.5倍（$30.1M vs $20.0M），Dominari Holdings Inc.净利率更高（-438.1% vs -541.1%，领先103.0%），Dominari Holdings Inc.同比增速更快（220.4% vs 86.1%），过去两年Dominari Holdings Inc.的营收复合增速更高（369.1% vs 56.1%）
Agios Pharmaceuticals是一家美国上市制药企业，创立于2008年，专注于开发针对基因定义疾病的创新疗法，近期核心方向为溶血性贫血治疗药物，总部位于马萨诸塞州剑桥市，2013年7月完成首次公开募股。
AGIO vs DOMH — 直观对比
营收规模更大
DOMH
是对方的1.5倍
$20.0M
营收增速更快
DOMH
高出134.3%
86.1%
净利率更高
DOMH
高出103.0%
-541.1%
两年增速更快
DOMH
近两年复合增速
56.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.0M | $30.1M |
| 净利润 | $-108.0M | $-131.8M |
| 毛利率 | 90.6% | — |
| 营业利润率 | -608.9% | -8.9% |
| 净利率 | -541.1% | -438.1% |
| 营收同比 | 86.1% | 220.4% |
| 净利润同比 | -11.9% | -12426.2% |
| 每股收益（稀释后） | $-1.86 | $-6.94 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGIODOMH
| Q4 25 | $20.0M | $30.1M | ||
| Q3 25 | $12.9M | $50.8M | ||
| Q2 25 | $12.5M | $34.1M | ||
| Q1 25 | $8.7M | $8.1M | ||
| Q4 24 | $10.7M | $9.4M | ||
| Q3 24 | $9.0M | $4.0M | ||
| Q2 24 | $8.6M | $6.2M | ||
| Q1 24 | $8.2M | $1.4M |
净利润AGIODOMH
| Q4 25 | $-108.0M | $-131.8M | ||
| Q3 25 | $-103.4M | $125.2M | ||
| Q2 25 | $-112.0M | $16.6M | ||
| Q1 25 | $-89.3M | $-32.5M | ||
| Q4 24 | $-96.5M | $1.1M | ||
| Q3 24 | $947.9M | $-4.2M | ||
| Q2 24 | $-96.1M | $-6.1M | ||
| Q1 24 | $-81.5M | $-5.4M |
毛利率AGIODOMH
| Q4 25 | 90.6% | — | ||
| Q3 25 | 87.0% | — | ||
| Q2 25 | 86.3% | — | ||
| Q1 25 | 87.6% | — | ||
| Q4 24 | 88.3% | — | ||
| Q3 24 | 91.3% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 92.3% | — |
营业利润率AGIODOMH
| Q4 25 | -608.9% | -8.9% | ||
| Q3 25 | -907.4% | -3.1% | ||
| Q2 25 | -1020.1% | -57.0% | ||
| Q1 25 | -1222.0% | -394.6% | ||
| Q4 24 | -1165.3% | 0.4% | ||
| Q3 24 | -1146.9% | -79.1% | ||
| Q2 24 | -1228.3% | -44.3% | ||
| Q1 24 | -1124.3% | -205.2% |
净利率AGIODOMH
| Q4 25 | -541.1% | -438.1% | ||
| Q3 25 | -803.1% | 246.4% | ||
| Q2 25 | -899.4% | 48.7% | ||
| Q1 25 | -1023.3% | -400.5% | ||
| Q4 24 | -899.6% | 11.4% | ||
| Q3 24 | 10574.7% | -104.2% | ||
| Q2 24 | -1115.7% | -99.1% | ||
| Q1 24 | -995.8% | -398.0% |
每股收益（稀释后）AGIODOMH
| Q4 25 | $-1.86 | $-6.94 | ||
| Q3 25 | $-1.78 | $7.27 | ||
| Q2 25 | $-1.93 | $1.12 | ||
| Q1 25 | $-1.55 | $-3.02 | ||
| Q4 24 | $-1.44 | $0.21 | ||
| Q3 24 | $16.22 | $-0.67 | ||
| Q2 24 | $-1.69 | $-1.01 | ||
| Q1 24 | $-1.45 | $-0.91 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.1M | $80.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.2B | $69.4M |
| 总资产 | $1.3B | $112.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AGIODOMH
| Q4 25 | $89.1M | $80.5M | ||
| Q3 25 | $92.7M | $176.2M | ||
| Q2 25 | $80.9M | $28.2M | ||
| Q1 25 | $79.0M | $18.9M | ||
| Q4 24 | $76.2M | $8.2M | ||
| Q3 24 | $253.7M | $7.2M | ||
| Q2 24 | $84.5M | $12.1M | ||
| Q1 24 | $118.8M | $7.1M |
股东权益AGIODOMH
| Q4 25 | $1.2B | $69.4M | ||
| Q3 25 | $1.3B | $210.2M | ||
| Q2 25 | $1.4B | $88.6M | ||
| Q1 25 | $1.5B | $42.4M | ||
| Q4 24 | $1.5B | $39.9M | ||
| Q3 24 | $1.6B | $38.3M | ||
| Q2 24 | $660.5M | $42.4M | ||
| Q1 24 | $743.9M | $47.7M |
总资产AGIODOMH
| Q4 25 | $1.3B | $112.9M | ||
| Q3 25 | $1.4B | $223.4M | ||
| Q2 25 | $1.5B | $109.3M | ||
| Q1 25 | $1.6B | $52.3M | ||
| Q4 24 | $1.7B | $47.1M | ||
| Q3 24 | $1.8B | $43.4M | ||
| Q2 24 | $773.1M | $49.1M | ||
| Q1 24 | $849.7M | $52.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-96.2M | $22.7M |
| 自由现金流经营现金流 - 资本支出 | $-97.3M | — |
| 自由现金流率自由现金流/营收 | -487.5% | — |
| 资本支出强度资本支出/营收 | 5.6% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-377.3M | — |
8季度趋势，按日历期对齐
经营现金流AGIODOMH
| Q4 25 | $-96.2M | $22.7M | ||
| Q3 25 | $-88.2M | $-4.9M | ||
| Q2 25 | $-77.1M | $-353.0K | ||
| Q1 25 | $-111.5M | $1.2M | ||
| Q4 24 | $-133.2M | $-16.7M | ||
| Q3 24 | $-84.2M | $-4.7M | ||
| Q2 24 | $-72.6M | $1.4M | ||
| Q1 24 | $-99.9M | $-8.6M |
自由现金流AGIODOMH
| Q4 25 | $-97.3M | — | ||
| Q3 25 | $-89.7M | — | ||
| Q2 25 | $-78.0M | — | ||
| Q1 25 | $-112.3M | — | ||
| Q4 24 | $-134.1M | — | ||
| Q3 24 | $-84.6M | — | ||
| Q2 24 | $-72.7M | — | ||
| Q1 24 | $-100.0M | — |
自由现金流率AGIODOMH
| Q4 25 | -487.5% | — | ||
| Q3 25 | -696.5% | — | ||
| Q2 25 | -626.2% | — | ||
| Q1 25 | -1286.4% | — | ||
| Q4 24 | -1250.1% | — | ||
| Q3 24 | -944.2% | — | ||
| Q2 24 | -844.4% | — | ||
| Q1 24 | -1221.2% | — |
资本支出强度AGIODOMH
| Q4 25 | 5.6% | — | ||
| Q3 25 | 12.1% | — | ||
| Q2 25 | 7.0% | — | ||
| Q1 25 | 8.8% | — | ||
| Q4 24 | 9.0% | — | ||
| Q3 24 | 4.7% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | 1.7% | — |
现金转化率AGIODOMH
| Q4 25 | — | — | ||
| Q3 25 | — | -0.04× | ||
| Q2 25 | — | -0.02× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -15.65× | ||
| Q3 24 | -0.09× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGIO
暂无分部数据
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
